Gemcitabine 1.4

Gemcitabine 1.4 g Injection
Gemcitabine 1.4 g Injection is a nucleoside analog antimetabolite anticancer drug used in the treatment of a wide range of solid tumors. It works by inhibiting DNA synthesis in rapidly dividing cancer cells, leading to suppression of tumor growth. Gemcitabine is widely used as monotherapy or in combination chemotherapy regimens.
Product Details
Generic Name: Gemcitabine (as Gemcitabine Hydrochloride)
Strength: 1.4 g (1400 mg)
Dosage Form: Injection (Sterile lyophilized powder for reconstitution)
Route of Administration: Intravenous (IV infusion)
Therapeutic Class: Antimetabolite Anticancer Agent
Indications
Gemcitabine 1.4 g Injection is indicated for the treatment of:
Pancreatic cancer
Non-small cell lung cancer
Breast cancer
Ovarian cancer
Bladder cancer
Biliary tract cancers
Mechanism of Action
Gemcitabine is incorporated into DNA during replication and inhibits DNA synthesis, leading to apoptosis (cell death) of cancer cells.
Key Benefits
Broad-spectrum activity against solid tumors
Widely used in combination chemotherapy protocols
Proven efficacy and safety profile
Accepted in global oncology treatment guidelines
Dosage & Administration
Dosage and treatment schedule are determined by the oncologist based on body surface area (BSA), cancer type, and patient condition. Administration should be carried out only under the supervision of qualified healthcare professionals.
Storage Conditions
Store below 25°C
Protect from light
Do not freeze
Precautions
For hospital and oncology clinic use only
Regular monitoring of blood counts is recommended
Use with caution in patients with hepatic or renal impairment